Volume 22 No 2 (2024)
 Download PDF
‘’The importance of monitoring serum calcium level in patients with Traumatic brain injury’’
Dr.Harsha Gupta, Dr Manish Singh, Dr. Ankush lokhande, Dr Kshama Shrivastava
Abstract
Introduction–Serum calcium is an important mediator of cell damage after TBI and cellular hypocalcemia may have a neuroprotective effect after brain injury Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Traumatic brain injury (TBI), sometimes referred to as acquired brain injury, significantly increases death and lifetime impairment. Traumatic brain injury accounts for 25% to 30% of all accidental deaths and 27% of trauma-related hospital deaths (TBI). Background: The present study has been conducted to assess whether hypocalcaemia can be used as a prognostic factor in the outcome of traumatic braininjury. Materials And Methods: This prospective study was done on 100 patients with moderate to severe traumatic brain injury in trauma centre of nscb medical college Jabalpur from 2020-2022. Serum calcium levels of patients had a Glasgow coma scale of 3–13 points following traumatic brain injury, with demonstrable intracraniallesionsincranial computed to mography were included. Student's t test, chi square test and Fisher's exact test were used for comparative analysis. Logistic regression and receiving operative curves analysis analysis were also done to assess the risk factors. Results: Statistically significantdifference were found in the Ca2+levels on the 3rd day of admission between the patients with GOS ≤3 and the patientswith GOS>3 (P=0.029). The best level of higher sensitivity (86.27%) and specificity (68.66%) of hypocalcaemia on 3rdday was the Ca2+ value of 1.14 mmol/L. Conclusion: The serum Ca2+levels on day 3 could be useful for the prediction of mortality and disability in patients with moderate to severe traumatic brain injury.
Keywords
Serum calcium is an important mediator of cell damage
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.